Treatment
Leukemia is treated mainly with chemotherapy, although radiotherapy and biological therapy can play a part with some forms of the disease. The goals of therapy are to relieve symptoms and obtain a remission. Remission is the condition in which leukemia is no longer detected and the bone marrow functions normally.
Treatment of leukemia, in general, is usually divided into two phases:
1. Induction. This is the attempt to attain a remission meaning that the bone marrow appears normal.
2. Consolidation. This involves giving the same or different treatment, even when the patient appears to be in remission because of the suspected or assumed presence of residual disease that cannot be detected.
Some patients may receive a third phase called maintenance treatment to prolong the remission. Maintenance treatment is more associated with the treatment of ALL (Acute Lymphoblastic Leukemia) than AML (Acute Myelogenous Leukemia).
Standard treatment for acute myeloid leukemia includes two drugs: Daunomycin (daunorubicin) and Cytosar (cytosine arabinoside). These are commonly given intravenously.
These drugs may cause significant nausea and vomiting, so patients are also given drugs such as Benadryl, Compazine, Vistaril, Reglan, and Ativan.
The chemotherapy drugs will kill normal and leukemic cells equally, so the most significant side effect besides nausea and vomiting is a temporary reduction of normal white blood cells and platelets. The deficiency of white cells means a loss of normal defenses against bacterial and fungal organisms leaving the patient open for infections. Low platelets mean that the patient may bruise or bleed easily. All patients are closely watched in the hospital until this effect is over.
Supportive treatment during the period of bone marrow recovery (after chemotherapy) includes blood and platelet transfusions and intravenous antibiotic treatment. Because of the intensive supportive treatment required, therapy for AML is often given in the hospital.
After remission is achieved, post-remission therapy can be curative. Options include repeated intensive chemotherapy with or without bone marrow transplantation, and high dose chemoradiotherapy with bone marrow transplantation.
(Back to Top)
|